Fig. 7From: MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1Kaplan-Meier survival curves for CRC patients. (a,b) The OS and DFS curves for CRC patients with high or low miR-106b expression. (c,d) The OS and DFS curves for CRC patients with high or low DLC1 expression. (e,f) The OS and DFS curves for CRC patients with concomitant miR-106b and DLC1 expressionBack to article page